Heartburn, Diabetes, and Blood Pressure Drugs May Contain Dangerously High Levels of a Carcinogen Called NDMA

Overseas manufacturers in China and elsewhere may at the root of the epidemic of various types of cancer from taking these medications

Thursday, June 4, 2020 - It seems as if every week a Zantac heartburn medication user files a lawsuit claiming that using the antacid medication caused a different type of cancer. Plaintiffs this year have alleged that using Zantac regularly and over many years caused their stomach, bladder, intestinal, prostate, breast, colon, and now pancreatic cancer. In addition to Zantac, the FDA has now been alerted by online drug testing pharmacy Valisure that other drugs including the most popular diabetic medication also contain dangerously high levels of N-Nitrosodimethylamine (NDMA), which is believed by the World Health Organization (WHO) to cause cancer in humans. In response to being alerted of this potential health crisis, the FDA has contacted metformin manufacturers and alerted them of the potential dangers and several companies have responded by pulling their diabetic drugs from the market. Zantac heartburn stomach cancer lawyers offer a free consultation to American families and individuals in the US before filing a claim.

Scientists and experts expect that overseas manufacturing processed in countries like China may be responsible for allowing NDMA to expand to carcinogenic levels when exposed to high drug storage temperatures or when the chemical interacts with nitrates, meat preservative, in the stomach. Bloomberg starting reporting on the potential health problem in July of 2018 and wrote: "Millions of blood-pressure pills known as angiotensin II receptor blockers were recalled beginning in July 2018 after being contaminated with the chemical during the manufacturing process, mainly at factories in China and India. The Senate Finance Committee is planning to hold a hearing next week to examine the FDA's ability to adequately inspect drug-production facilities overseas."

WebMD reports that a diabetic drug company has already reacted to the news by recalling their drugs and that others are sure to follow suit. "A recall of the widely-used diabetes drug metformin was announced by drug maker Apotex, due to possible high levels of N-Nitrosodimethylamine (NDMA), which is believed to cause cancer in people. The recall for all lots of metformin hydrochloride extended-release tablets 500 mg from Apotex comes after one lot tested by the U.S. Food and Drug Administration had higher NDMA levels than allowed by the FDA, " Web MD reports.

Ironically, diabetic drugs like metformin are prescribed by doctors as a form of diabetes therapy that is to be taken along with the patient making changes to their diet and exercise habits. It is the same poor diet that leads a person to reach for the Zantac antacid that also leads to a person eventually developing diabetes, a more serious and often fatal disease. Changing one's diet is thought to be therapy enough to combat obesity, heartburn and acid reflux, and also to prevent or even reverse diabetes. Doctors that are educated in nutrition often recommend reducing coffee, alcohol, or eating spicy foods and switching to a more natural whole food, plant-based diet. An exercise that improves blood circulation and fresh oxygen intake can be as simple as getting out at sunrise or near sunset and walking for 30 minutes or more. More importantly, diabetic patients should not stop taking their prescribed diabetic medication until told to do so by their physician prescribing the medication as stopping the medication could lead to the disease progressing and possibly death.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.